Takeda Pharmaceutical Company Limited Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement
Takeda Pharmaceutical Company Limited (TKPHF) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement of JPY 3.72 thousand for the 12-month period ending 2019-03-31, per its 20-F filed 2019-06-27.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement · last filed 2019-06-27
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement 12 month |
|---|---|
| 2019-03-31 | 3.72K JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 3.88K JPY 20-F · filed 2019-06-27 |
| 2017-03-31 | 2.12K JPY 20-F · filed 2019-06-27 |